It remains unclear what, exactly, NGS would do to justify its cost (even if it drove to nearly free). It's been sold as a health panacaea for decades and has proven to not be that, repeatedly. Some gene tests are useful but it's clear that most disease phenotypes require much deepeer analysis than we are currently able to apply.